SAN MATEO, Calif.–(BUSINESS WIRE)–Nationally over 230,000 primary care physicians (PCPs) and specialists are evaluated based on achieving acceptable clinical protocol ranges in treating medical conditions (or Clinical MedMarker Protocol Ranges™). “CCGroup works with CCGroup National Specialist Panels on an ongoing basis. This effort helps to ensure the validity of established Clinical MedMarker Protocol Ranges™,” stated Dr. Douglas G. Cave, President of CCGroup. CCGroup is the market innovator and leader in reliably measuring physician efficiency. Dr. Cave continued, “MedMarkers™ are process of care quality measures, well-defined in clinical guidelines. However, they also are the key services and procedures most associated with cost-of-care in treating a medical condition. MRI of spine is the main MedMarker™ (or correlated service) in treating low back pain; and upper gastrointestinal (GI) endoscopy is the main MedMarker™ in treating GERD (or heartburn). MedMarkers™ technology is protected under USPTO Patent Numbers 8,301,464 and 8,751,263.”
